drugset / Trial / NCT00306137

Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal Cancer

NCT00306137

Phase 3 Terminated 104 enrolled Bayer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal Cancer.

Timeline

Start
2005-12
Primary completion
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Aprotinin Unknown 500000 unknown

Indications

No indication recorded.